• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中多巴胺和食欲素的进行性缺乏:对睡眠和觉醒有影响吗?

Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?

机构信息

Department of Neurology, University Hospital, Zurich, Switzerland.

出版信息

J Sleep Res. 2012 Dec;21(6):710-7. doi: 10.1111/j.1365-2869.2012.01027.x. Epub 2012 Jul 2.

DOI:10.1111/j.1365-2869.2012.01027.x
PMID:22747735
Abstract

Sleep-wake disturbances are frequent in patients with Parkinson's disease, but prospective controlled electrophysiological studies of sleep in those patients are surprisingly sparse, and the pathophysiology of sleep-wake disturbances in Parkinson's disease remains largely elusive. In particular, the impact of impaired dopaminergic and hypocretin (orexin) signalling on sleep and wakefulness in Parkinson's disease is still unknown. We performed a prospective, controlled electrophysiological study in patients with early and advanced Parkinson's disease, e.g. in subjects with presumably different levels of dopamine and hypocretin cell loss. We compared sleep laboratory tests and cerebrospinal fluid levels with hypocretin-deficient patients with narcolepsy with cataplexy, and with matched controls. Nocturnal sleep efficiency was most decreased in advanced Parkinson patients, and still lower in early Parkinson patients than in narcolepsy subjects. Excessive daytime sleepiness was most severe in narcolepsy patients. In Parkinson patients, objective sleepiness correlated with decrease of cerebrospinal fluid hypocretin levels, and repeated hypocretin measurements in two Parkinson patients revealed a decrease of levels over years. This suggests that dopamine and hypocretin deficiency differentially affect sleep and wakefulness in Parkinson's disease. Poorer sleep quality is linked to dopamine deficiency and other disease-related factors. Despite hypocretin cell loss in Parkinson's disease being only partial, disturbed hypocretin signalling is likely to contribute to excessive daytime sleepiness in Parkinson patients.

摘要

睡眠-觉醒障碍在帕金森病患者中很常见,但对这些患者睡眠进行前瞻性对照电生理学研究的却少之又少,帕金森病睡眠-觉醒障碍的病理生理学仍然很大程度上难以捉摸。特别是,多巴胺能和下丘脑分泌素(食欲素)信号受损对帕金森病睡眠和觉醒的影响仍不清楚。我们对早期和晚期帕金森病患者进行了前瞻性对照电生理学研究,例如在多巴胺和下丘脑分泌素细胞丢失程度不同的患者中进行研究。我们将睡眠实验室测试和脑脊液水平与伴有猝倒的发作性睡病伴下丘脑分泌素缺乏患者以及匹配的对照组进行了比较。晚期帕金森病患者的夜间睡眠效率下降最明显,而早期帕金森病患者的睡眠效率仍低于发作性睡病患者。白天过度嗜睡在发作性睡病患者中最为严重。在帕金森病患者中,客观嗜睡与脑脊液下丘脑分泌素水平下降相关,对两名帕金森病患者的重复下丘脑分泌素测量显示,水平随时间下降。这表明多巴胺和下丘脑分泌素缺乏会以不同的方式影响帕金森病患者的睡眠和觉醒。较差的睡眠质量与多巴胺缺乏和其他与疾病相关的因素有关。尽管帕金森病中下丘脑分泌素细胞的丢失只是部分的,但下丘脑分泌素信号的紊乱可能会导致帕金森病患者白天过度嗜睡。

相似文献

1
Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?帕金森病中多巴胺和食欲素的进行性缺乏:对睡眠和觉醒有影响吗?
J Sleep Res. 2012 Dec;21(6):710-7. doi: 10.1111/j.1365-2869.2012.01027.x. Epub 2012 Jul 2.
2
Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.发作性睡病伴猝倒症中下丘脑分泌素缺乏与正常的核心体温调节有关。
Chronobiol Int. 2010 Sep;27(8):1596-608. doi: 10.3109/07420528.2010.504907.
3
Narcolepsy in Parkinson's disease.帕金森病中的嗜睡症。
Expert Rev Neurother. 2010 Jun;10(6):879-84. doi: 10.1586/ern.10.56.
4
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.帕金森病痴呆患者的脑脊液食欲素、日间嗜睡和睡眠结构。
Brain. 2009 Dec;132(Pt 12):3308-17. doi: 10.1093/brain/awp263.
5
Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.下丘脑泌素/食欲素与睡眠:对发作性睡病病理生理学及诊断的意义
Curr Opin Neurol. 2002 Dec;15(6):739-45. doi: 10.1097/01.wco.0000044800.53746.5a.
6
Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.症状性发作性睡病、猝倒和嗜睡症及其在下丘脑分泌素/食欲素系统中的意义。
Sleep Med Rev. 2005 Aug;9(4):269-310. doi: 10.1016/j.smrv.2005.03.004.
7
Sleepiness that cannot be overcome: narcolepsy and cataplexy.无法克服的嗜睡:发作性睡病和猝倒症。
Respirology. 2012 Nov;17(8):1157-65. doi: 10.1111/j.1440-1843.2012.02178.x.
8
CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.帕金森病、路易体痴呆、进行性核上性麻痹和皮质基底节变性患者脑脊液中食欲素水平
J Neurol Sci. 2006 Dec 1;250(1-2):120-3. doi: 10.1016/j.jns.2006.08.004. Epub 2006 Sep 26.
9
Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.四名帕金森病患者的脑脊液中食欲素水平与睡眠发作
Clin Neurol Neurosurg. 2009 May;111(4):341-4. doi: 10.1016/j.clineuro.2008.11.007. Epub 2008 Dec 20.
10
The neurochemistry of awakening: findings from sleep disorder narcolepsy.觉醒的神经化学:睡眠障碍性嗜眠症的发现。
Int Rev Neurobiol. 2010;93:229-55. doi: 10.1016/S0074-7742(10)93010-9.

引用本文的文献

1
The orexin/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment.痴呆相关神经疾病中的食欲素/下丘脑泌素系统:认知障碍中的双刃剑
Psychopharmacology (Berl). 2025 Jun 16. doi: 10.1007/s00213-025-06839-2.
2
Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship.睡眠障碍与帕金森病的交集:揭示双向关系
Mov Disord Clin Pract. 2025 Jan;12(1):11-20. doi: 10.1002/mdc3.14254. Epub 2024 Nov 7.
3
Sex-dimorphic functions of orexin in neuropsychiatric disorders.
食欲素在神经精神疾病中的性别二态性功能。
Heliyon. 2024 Aug 15;10(16):e36402. doi: 10.1016/j.heliyon.2024.e36402. eCollection 2024 Aug 30.
4
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review.食欲素与α-突触核蛋白病中的睡眠障碍:系统综述。
Curr Neurol Neurosci Rep. 2024 Sep;24(9):389-412. doi: 10.1007/s11910-024-01359-6. Epub 2024 Jul 20.
5
Sleep macro-architecture in patients with Parkinson's disease does not change during the first night of neurostimulation in a pilot study.在一项试点研究中,帕金森病患者在接受神经刺激的第一个晚上,其睡眠宏观结构没有变化。
J Clin Sleep Med. 2024 Sep 1;20(9):1489-1496. doi: 10.5664/jcsm.11180.
6
Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson's Disease with Sleep Disorders.低水平的腺苷和胶质细胞源性神经营养因子是帕金森病伴睡眠障碍的潜在危险因素。
Brain Sci. 2023 Jan 24;13(2):200. doi: 10.3390/brainsci13020200.
7
Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study.帕金森病患者脑脊液食欲素水平降低与临床睡眠障碍无关:一项回顾性研究。
PLoS One. 2022 Dec 30;17(12):e0279747. doi: 10.1371/journal.pone.0279747. eCollection 2022.
8
Association between Sleep, Alzheimer's, and Parkinson's Disease.睡眠、阿尔茨海默病与帕金森病之间的关联。
Biology (Basel). 2021 Nov 3;10(11):1127. doi: 10.3390/biology10111127.
9
Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity.关注癌症、发作性睡病与其他神经退行性疾病之间的复杂相互联系:一种可能的食欲素依赖型反向共病情况。
Cancers (Basel). 2021 May 26;13(11):2612. doi: 10.3390/cancers13112612.
10
Shedding Light on Nocturnal Movements in Parkinson's Disease: Evidence from Wearable Technologies.揭示帕金森病夜间运动:可穿戴技术的证据。
Sensors (Basel). 2020 Sep 10;20(18):5171. doi: 10.3390/s20185171.